Security key
462260100
IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA)
CUSIP: 462260100
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 213,023,331
- Total 13F value
- $462,262,436
- Share change
- -7,201,156
- Put/Call ratio
- 70%
- SEC-reported price per share
- $2.17
- Number of holders
- 249
- Value change
- -$12,426,646
- Number of buys
- 119
- Number of sells
- 114
- Shares outstanding
- 445,059,418
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
249
Top holders
10
IOVA full security history
Ownership snapshot
Full 13F holder table
IOVANCE BIOTHERAPEUTICS, INC. SEC filings
IOVANCE BIOTHERAPEUTICS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
MHR FUND MANAGEMENT LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
3/4/5
13F
Lead comparable stake: 3.8%
13D/G row: PERCEPTIVE ADVISORS LLC
Showing 1-6 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 3.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
PERCEPTIVE ADVISORS LLC
3.8%
Matthew William Rosinack
0.02%
MHR FUND MANAGEMENT LLC
6.5%
VANGUARD GROUP INC
5.6%
BlackRock, Inc.
5.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13D/G
|
3.8%
|
$45,599,285
12,808,788 shares
|
-$33,120,382 | 31 Mar 2025 |
| Matthew William Rosinack |
3/4/5
SVP, Finance (Int. PFO & PAO)
|
0.02%
|
$153,382
89,129 shares
|
— | 30 Jun 2025 |
| MHR FUND MANAGEMENT LLC |
13F
Company
|
6.5%
|
$49,823,417
28,967,103 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
5.6%
|
$43,131,531
25,076,472 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
5.2%
|
$39,967,317
23,236,812 shares
|
— | 30 Jun 2025 |
| Long Focus Capital Management, LLC |
13F
Company
|
2.7%
|
$20,330,400
11,820,000 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
249
Shares
213,023,331
Rows available
249
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
244
Q3 2025 holders
249
Holder diff
5
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|